EMEA-001289-PIP01-12-M01 - paediatric investigation plan
Autologous CD34+ cells transduced ex-vivo with retroviral vector (GIADAl) containing human adenosine deaminase gene from cDNA
PIPHuman
Orchard Therapeutics (Netherlands) B.V.
regulatory@orchard-tx.com
Tel. +44 (0) 20 3808 8286
P/0190/2014: EMA decision of 6 August 2014 on the acceptance of a modification of an agreed paediatric investigation plan for autologous CD34+ Cells Transduced ex-vivo with Retroviral Vector (GIADAl) Containing Human Ade...